Feed Anticoccidials Market Forecasts to 2028 – Global Analysis By Type (Monensin, Salinomycin and Other Types), Livestock (Poultry, Ruminant, Swine and Other Livestocks), Mode of Consumption (Oral and Injection), Form (Dry and Liquid), Source (Chemical an

Feed Anticoccidials Market Forecasts to 2028 – Global Analysis By Type (Monensin, Salinomycin and Other Types), Livestock (Poultry, Ruminant, Swine and Other Livestocks), Mode of Consumption (Oral and Injection), Form (Dry and Liquid), Source (Chemical and Natural) and By Geography

According to Stratistics MRC, the Global Feed Anticoccidials Market is accounted for $372.18 million in 2022 and is expected to reach $533.96 million by 2028 growing at a CAGR of 6.2% during the forecast period. Feed anticoccidials are commonly used as an additive in feed and veterinary medications and are used to treat coccidial infections in poultry and other animals. These are substances that are active and made by the bacteria Streptomyces albus. They are polyether ionophore antibiotics. Since coccidiosis is an infectious disease of the intestinal tract that affects both domestic and wild animals, the coccidia are to blame for significant financial losses to the livestock industry.

According to Depart of Animal Husbandry and Dairying, contribution from poultry meat sector was contributed to be 75.32% and poultry egg sector contributed to be 24.67% in India. In addition, the annual production of poultry meat was 4.06 metric tons in the year 2018-2019.

Market Dynamics

Driver:

Rising consumer awareness towards the poultries and other animals

There have been numerous changes in the population's dietary habits and consumption patterns, which have led to a shift towards more people eating poultry. In addition, the government launches a number of campaigns to raise public awareness of the value of animal health. Anticoccidials used in animal feed have drawn a lot of attention because they are essential for maintaining the immunity and gut health of animals. Natural animal feed additives with minimal side effects are becoming more and more in demand. Due to this, demand has increased, primarily among producers of poultry. The market for animal feed anticoccidials is consequently growing due to the rising prevalence of chronic diseases linked to the consumption of animal byproducts.

Restraint

Restrictions in European Union

Due to the emergence of microorganisms that are resistant to antibiotics used to treat human and animal infections, the European Union banned the use of antibiotics as growth promoters in 2006. In many nations around the world, especially in places like China, India, and the United States, the use of antibiotic remedies has decreased since the European Union's ban on their use was lifted. This caused a sizable loss in revenue for these antibiotic treatments in the affected nations.

Opportunity

Increasing prevalence of coccidiosis in poultry industry

The primary driver of feed anticoccidial is the rising incidence of coccidiosis in poultry. Chickens and other birds are susceptible to the parasitic protozoa disease coccidiosis, which causes intestinal illness. Coccidiosis has become much more commonplace in recent years. The emergence of new parasite strains that are more resilient to drug treatment coincides with this trend. Additionally, during the forecast period, the development of high-quality and new raw materials as well as emerging new markets will further create lucrative and rewarding growth opportunities for the feed anticoccidials market.

Threat

Research for safer alternatives to control coccidiosis

The resistance of various Eimeria spp. to drugs and consumer pressure to buy poultry products free of drug residues were the two main drawbacks to using coccidiostats in poultry. This circumstance served as a catalyst for research into finding secure alternatives. Finding plants with compounds that are effective at preventing Eimeria spp. from multiplying was the common goal of the majority of these studies. The evaluated herbs with anticoccidial properties have been the subject of documented studies and their extracts. These outcomes may limit market expansion in the near future.

Covid-19 Impact

The initial COVID-19 lockdown affected the global supply of poultry feed and disrupted the logistics system. In the beginning, there had been restrictions and closures of poultry feed businesses all over the world, which led to a shortage of feed for livestock farmers. The supply of food products was insufficient as many of the manufacturers shut down due to a labor shortage, along with mass production shutdowns and supply chain disruptions. The high reliance on home-prepared vegetarian food as a result of the COVID-19 virus fear and the lockdown that prevented people from leaving their homes are a couple of the other factors that contributed to the decline in sales of feed anticoccidial during the pandemic.

The Poultry segment is expected to be the largest during the forecast period

Due to the presence of coccidia, one of the more common parasitic diseases in poultry is the use of antibiotics. Therefore, the poultry segment is expected to register the largest share during the forecast period. As a result of co-limiting the coccidia, this infectious infection develops in the intestine. Coccidial poisoning can have a significant negative impact on poultry, and it has the potential to economically disrupt the poultry industry. For this reason, it is crucial to put in place the proper controls to stop any coccidial poisoning. The main requirements to stop coccidiosis in poultry are vaccination campaigns and the use of anti-coccidiotic medications for both prophylaxis and treatment.

The Salinomycin segment is expected to have the highest CAGR during the forecast period

During the forecast period, the salinomycin segment is expected to witness lucrative growth. Salinomycin is an antibiotic that is a monocarboxylic polyether and is produced when Streptomyces albus ferments. Salinomycin's primary mechanism of action involves ionophoric activity, primarily through the binding of monovalent cations like potassium, sodium, rubidium, and lithium, which are then channeled into livestock cells in a complex manner. It is the fastest-growing market segment globally due to its lower cost compared to other anticoccidials and easy availability.

Region with largest share

Owing to the enormous number of domesticated animals in the region, Asia Pacific is expected to witness the largest share over the forecast period. Due to factors like rising health spending, particularly in India and China, and growing awareness of animal health over the past few years, the animal healthcare market in Asia Pacific has undergone significant changes. Significant increases in livestock breeding for the production of meat and poultry were also observed in China and India. Livestock producers are putting more emphasis on animal healthcare and overusing livestock antibiotics, such as anticoccidials, to satisfy the rising demand for milk and meat products. Such elements are accelerating the growth in this area.

Region with highest CAGR

During the forecast period, North America is anticipated to register the highest growth rate. The market's need in this area is being driven by an increase in the need to guarantee the quality of poultry products and an increase in production rates. Moreover, the government's increasing investments in pharmaceutical firms also broaden the market's demand. Following the United States in capturing the largest market share is Canada. One of the main drivers of market expansion in this nation is the expansion of the livestock population. The increasing demand for high-quality meat products is credited with accelerating the market's growth rate in this region.

Key players in the market

Some of the key players profiled in the Feed Anticoccidials Market include Bioproperties Pty. Ltd., Ceva Animal Health, Elanco Animal Health, Huvepharma, Impextraco, Kemin Industries, Merck Animal Health, Phibro Animal Health, Qilu Animal Health Products Co. Ltd., Virbac S.A, Zydus Animal Health and Zoetis.

Key Developments

In February 2023, Elanco Animal Health announces the addition of PenPoint™ Sort to help cattle feeders maximize profitability. PenPoint Sort adds to the existing Elanco Knowledge Solutions portfolio of services designed to optimize practices and products through trusted tools, technologies and insights to empower data-driven decision making.

In February 2023, Elanco Animal Health announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’s innovative feline portfolio while addressing an unmet need for this chronic condition in adult cats.

In December 2022, Ceva Santé Animale (Ceva) announces the acquisition of the Argentinian companies Zoovet - specialized in the production and marketing of animal health products and Biotecnofe - a biotech start-up developing innovative products to be distributed by Zoovet.

Type Covered:
• Monensin
• Salinomycin
• Lasalocid
• Narasin
• Diclazuril
• Other Types

Livestock Covered:
• Poultry
• Ruminant
• Swine
• Other Livestocks

Consumptions Covered:
• Oral
• Injection

Forms Covered:
• Dry
• Liquid

Sources Covered:
• Chemical
• Natural

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements